*Avastin-Folfoxiri better than Avastin-Folfiri, no news there. It is just a repeat of things we knew would happen.
*In Colon cancer patients with Wild type KRAS Panitumumab (Vectibix) associated to 5-FU based combination gave an outcome comparable to results obtained in a different study with Avastin and 5-FU based combination. 2 phase II trials but 2 similar outcomes. And this in first line and 2nd line. Can't wait to see a phase III.
*40% Glioblastoma express EGFR
20% have EGFRvIII
with Lapatinip being looked at for treatment, will wait to see.
Showing posts with label lapatinip. Show all posts
Showing posts with label lapatinip. Show all posts
Thursday, March 7, 2013
Subscribe to:
Posts (Atom)